Codexis, Inc.
CDXS
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvā¦ read more
Healthcare
Biotechnology
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.69
Price-16.95%
-$0.35
1Y
Price
Market Cap
$143.358m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-83.9%
EBITDA Margin-86.6%
Net Profit Margin-133.6%
Free Cash Flow MarginRevenue
$57.164m
-3.7%
1y CAGR-22.8%
3y CAGR-9.0%
5y CAGREarnings
-$64.976m
+0.5%
1y CAGR-37.4%
3y CAGR-42.5%
5y CAGREPS
-$0.83
+6.7%
1y CAGR-30.8%
3y CAGR-36.7%
5y CAGRBook Value
$55.631m
$138.246m
Assets$82.615m
Liabilities$68.980m
DebtDebt to Assets
49.9%
-1.3x
Debt to EBITDAFree Cash Flow
-$67.767m
-26.2%
1y CAGR-678.9%
3y CAGR-481.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company